CB-PRP in Retinitis Pigmentosa and Dry Age-related Macular Degeneration
Condition(s):Retinitis Pigmentosa; Dry Age-related Macular DegenerationLast Updated:January 11, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Retinitis Pigmentosa; Dry Age-related Macular DegenerationLast Updated:January 11, 2023Completed
Condition(s):Lymphoma; Myeloma; Leukemia; Myelodysplasia; Solid Tumors; Hodgkin’s Disease; MyelofibrosisLast Updated:May 16, 2014Completed
Condition(s):Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic SyndromesLast Updated:October 12, 2017Completed
Condition(s):Hematopoietic and Lymphoid Cell NeoplasmLast Updated:November 13, 2018Terminated
Condition(s):Acute Leukemia; Immune Deficiency Disorder; Congenital Hematological Disorder; Metabolism Disorder; Aplastic Anemia; Myelodysplastic Syndromes; Chronic Leukemia; Lymphoma; Multiple Myeloma; Solid TumorLast Updated:July 19, 2023Recruiting
Condition(s):Diabetic Foot UlcersLast Updated:July 21, 2017Completed
Condition(s):Acute LeukemiaLast Updated:April 23, 2012Completed
Condition(s):Cerebral PalsyLast Updated:October 7, 2022Withdrawn
Condition(s):Infant, Extremely Premature; Erythrocyte Transfusion; Umbilical Cord IssueLast Updated:November 10, 2022Not yet recruiting
Condition(s):Non-Hodgkin’s Lymphoma; Hodgkin’s Lymphoma; Multiple Myeloma; Chronic Lymphocytic Leukemia; Acute Myelogenous LeukemiaLast Updated:January 23, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.